Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies.

Procopio, G; Verzoni, E; Iacovelli, R; Biasoni, D; Testa, I; Porcu, L; De Braud, F

Procopio, G; Verzoni, E; Iacovelli, R; Biasoni, D; Testa, I; Porcu, L; De Braud, F.

Affiliation

Procopio G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. giuseppe.procopio@istitutotumori.mi.it

Br J Cancer ; 107(8): 1227-32, 2012 Oct 09.

Article in En | MEDLINE | ID: mdl-22968651

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Carcinoma, Renal Cell/drug therapy; Kidney Neoplasms/drug therapy; Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell/classification; Carcinoma, Renal Cell/mortality; Carcinoma, Renal Cell/secondary; Databases, Factual; Female; Humans; Kidney Neoplasms/classification; Kidney Neoplasms/mortality; Kidney Neoplasms/pathology; Male; Middle Aged; Molecular Targeted Therapy; Predictive Value of Tests; Prognosis; Survival Analysis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Antineoplastic Combined Chemotherapy Protocols / Kidney Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2012 Type: Article Affiliation country: Italy

Fulltext

XML

PubMed Links

Search on Google